In this article by Manufacturing Chemist, Thierry Van Nieuwenhove, CEO of Quotient Sciences, discusses the future of pharma manufacturing.
Ahead of the upcoming DCAT, Dr. Kevin Robinson caught up with pharmaceutical industry experts to discuss how they’re innovating for resilience and sustainability in 2025 and beyond.
Thierry Van Nieuwenhove, CEO of Quotient Sciences recognizes that sustainability and resilience are critical to the future of pharmaceutical development supply chains.
Continue reading the full article on Manufacturing Chemist.